Hu Yan, Wan Chao, Yang Xiao, Tian Yu, Deng Suke, An Dandan, Wang Yijun, Wang Jiacheng, Liao Zhiyun, Meng Jingshu, Qin You, Sun Yajie, Yang Kunyu
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Bioeng Biotechnol. 2023 Jun 5;11:1156951. doi: 10.3389/fbioe.2023.1156951. eCollection 2023.
Stem-like tumor cells (SLTCs) are thought to be the cellular entity responsible for clinical recurrence and subsequent metastasis. Inhibiting or killing SLTCs can effectively reduce recurrence and metastasis, yet little has been done to clear SLTCs because they are usually resistant to chemotherapy, radiotherapy, and even immunotherapy. In this study, we established SLTCs by low-serum culture and confirmed that the low-serum-cultured tumor cells were in a quiescent state and resistant to chemotherapy, showing features of SLTCs, consistent with the reported data. We demonstrated that SLTCs had high levels of reactive oxygen species (ROS). Based on the finding that radiated tumor cell-derived microparticles (RT-MPs) contained ROS, we used RT-MPs to kill SLTCs. We found that RT-MPs could further increase ROS levels and kill SLTCs and partially by ROS carried by the RT-MPs themselves, providing a new method for eliminating SLTCs.
干细胞样肿瘤细胞(SLTCs)被认为是导致临床复发和后续转移的细胞实体。抑制或杀死SLTCs可有效降低复发和转移,但由于SLTCs通常对化疗、放疗甚至免疫疗法具有抗性,因此在清除SLTCs方面进展甚微。在本研究中,我们通过低血清培养建立了SLTCs,并证实低血清培养的肿瘤细胞处于静止状态且对化疗具有抗性,表现出SLTCs的特征,与已报道的数据一致。我们证明SLTCs具有高水平的活性氧(ROS)。基于辐射肿瘤细胞衍生的微粒(RT-MPs)含有ROS这一发现,我们使用RT-MPs来杀死SLTCs。我们发现RT-MPs可进一步提高ROS水平并杀死SLTCs,且部分是通过RT-MPs自身携带的ROS实现的,这为消除SLTCs提供了一种新方法。